(Q33377564)

26 July 2017

title

Anti-platelet antibodies in a natural animal model of sulphonamide-associated thrombocytopaenia (English)

1 reference

26 July 2017

1 reference

Sidonie N Lavergne

1

1 reference

26 July 2017

Lauren A Trepanier

series ordinal

2

1 reference

26 July 2017

publication date

1 December 2007

1 reference

26 July 2017

1 reference

26 July 2017

volume

18

1 reference

26 July 2017

issue

8

1 reference

26 July 2017

page(s)

595-604

1 reference

Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968-91.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Drug-induced immune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Clinical practice. Heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Drug-induced immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Idiosyncratic toxicity associated with potentiated sulfonamides in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Role of animal models in the study of drug-induced hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Clinical Findings in 40 Dogs with Hypersensitivity Associated with Administration of Potentiated Sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Molecular mechanisms of drug-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Interaction of integrin alpha IIb beta 3 with multiple fibrinogen domains during platelet adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Clinical, biochemical, and molecular aspects of Glanzmann's thrombasthenia in humans and dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Allergic adverse reactions to sulfonamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Platelet function and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Drug metabolism, danger signals, and drug-induced hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Can drugs cause autoimmune thrombocytopenic purpura?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Practical Issues in the Management of Hypersensitivity Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100701392913

10.1080/09537100701392913

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference